Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by fredgoodwinson on Aug 19, 2020 7:05am

Coronavirus

https://web.tmxmoney.com/article.php?newsid=4753647751433736&qm_symbol=TLT
Comment by investclub on Aug 19, 2020 7:19am
2 words Fred  ..  absolutely amazing 
Comment by investclub on Aug 19, 2020 8:28am
Does this news imply that should they be successful in Covid-19 destruction it will also work on other viruses?  Dr Coombs also stated "Based upon the above results, I believe further studies are strongly warranted. Theralases's PDCs show great promise as a potential therapeutic. Given the similar physicochemical properties of all enveloped viruses, including the new coronavirus ...more  
Comment by LaserStock29 on Aug 19, 2020 8:36am
So is Dr Mandel done with GBM GMP and Non GMP and filed for Phase 1 GBM Where does he find the time lol Interesting stuff
Comment by investclub on Aug 19, 2020 9:04am
LaserStock29 wrote So is Dr Mandel done with GBM GMP and Non GMP and filed for Phase 1 GBM Where does he find the time lol Interesting stuff I believe the GBM GMP and NON GMP is still in the works however it looks like the extension of cancer indications to be announced are coming  ...  lining up NMIBC, RPCCC lung cancer and now Covid-19    too bad for those that didn't ...more  
Comment by Thor6570 on Aug 19, 2020 8:39am
Well they have show in earlier work effectiveness against bacteria however they have not pursued to my knowledge.
Comment by Mikee3003 on Aug 19, 2020 9:40am
Great news....thinking of some other studies that could possibly tie into this. Say someone with Non-Hodgkins Lymphoma comes down with Covid and is eligible to be treated with TLT PDC's. Folicular lymphoma for example is often treated with low dose external beam radiation therapy so could this be used to activate the PDC's and knockout the covid virus along with the cancer?? Exciting ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250